Characterization of a novel HLA-A*11:335 allele resulting from a rare interlocus recombination involving HLA-A*11:01:01:01/126 and HLA-H*02:07/14/18 alleles with nanopore sequencing, in a volunteer from the China Marrow Donor Program

Table 1 The typing results of sample 17ZZ2298 for HLA-A, B, C, DRB1, and DQB1 with different types of reagents and methods

Reagents	Methods	HLA-A		HLA-B		HLA-DRB1		HLA-C		HLA-DQB1
BGI	Hiseq	01:01	11:01	15:32	57:01	07:01	12:01	06:02	12:03	03:01	03:03
CSTB	Sanger1	01:01	11:126	15:32	57:01	07:01	12:01	06:02	12:03	03:01	03:03
Biocapital	Sanger2	01:01	11:126
Onelambda	SSO	01:01	11:01
Onelambda	Miseq1	01:01	11:126
GenDx	Sanger3	01:01	11:126
GenDx	Miseq2	01:01	11:335	Final nomenclature
ONT	MinION	01:01	11:335	Final nomenclature

The bold 11:335 and final nomenclature means: The name HLA-A*11:335 was officially assigned by the WHO Nomenclature Committee in May 2019

ISSN: 1755-8794